Kiniksa Pharmaceuticals, Ltd.

NASDAQ:KNSA

22.99 (USD) • At close November 12, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Omzet 112.214108.63179.85883.39567.04671.47348.34561.88499.13526.97232.18918.74512.0957.70400000000000000000
Kosten van de omzet 49.41642.45531.53826.75926.39921.6857.03614.23211.565.0294.2193.8672.7672.4660.8830000000000000000
Brutowinst 62.79866.17648.3256.63640.64749.78841.30947.65287.57521.94327.9714.8789.3285.238-0.8830000000000000000
Brutowinstmarge 0.560.6090.6050.6790.6060.6970.8540.770.8830.8140.8690.7940.7710.6800000000000000000
Onderzoek- en ontwikkelingskosten 26.05723.89826.1819.81617.10623.76715.17214.3916.48513.79820.81727.43319.23623.94528.68337.39831.41922.32420.90122.88622.01430.84859.25336.12220.64417.212.6329.93114.0089.2723.145
Algemene en administratieve kosten 00000000000000015.511.7999.5368.4869.6958.4328.4418.3948.0135.5154.3273.712.782.2412.121.903
Verkoop- en marketingkosten 0000000000000001.40-0.6-0.8000000000000
Verkoop-, algemene en administratieve kosten 46.39942.39538.68236.73934.46829.17529.04527.21524.67723.84122.21822.74120.75921.84820.615.511.7999.5368.4869.6958.4328.4418.3948.0135.5154.3273.712.782.2412.121.903
Overige kosten 20.1092.4212.2662.3692.4281.9158.2880.7946.9373.6728.2540.8352.7672.46600000000000000000
Bedrijfskosten 72.45666.29364.86256.55551.57452.94252.50541.60541.16241.31151.28951.00939.99545.79349.28352.89843.21831.8629.38732.58130.44639.28967.64744.13526.15921.52716.3432.71116.24911.3925.048
Bedrijfsresultaat -9.658-0.117-16.5420.081-10.927-3.154-11.1966.04746.413-19.368-23.251-36.131-30.667-40.555-49.283-52.898-43.218-31.86-29.387-32.581-30.446-39.289-67.647-44.135-26.159-21.527-16.34-32.711-16.249-11.392-5.048
Bedrijfsresultaat ratio -0.086-0.001-0.2070.001-0.163-0.044-0.2320.0980.468-0.718-0.722-1.928-2.536-5.26400000000000000000
Totaal overige inkomsten en kosten netto 2.4572.4212.2662.3692.4281.9151.8320.7940.3220.103-0.0340.0770.0050.0060.0090.030.0490.2660.7891.131.3861.7241.8091.7271.6221.0660.3050.1330.1690.1530.074
Inkomen voor belasting -7.2012.304-14.2762.45-8.499-1.239-9.3646.84146.735-19.265-23.285-36.054-30.662-40.549-49.274-52.868-43.169-31.594-28.598-31.451-29.06-37.565-65.838-42.408-24.537-20.461-16.035-32.578-16.08-11.239-4.974
Inkomen voor belasting ratio -0.0640.021-0.1790.029-0.127-0.017-0.1940.1110.471-0.714-0.723-1.923-2.535-5.26300000000000000000
Belastingkosten 5.4926.2123.428-22.7875.356-16.2112.9062.38-177.3580.7161.9250.279-0.1181.0140.210.7890.6675.875-2.1790.346-2.002-0.374-0.0170.172-0.131-0.202-0.0530.123-0.051-0.036-0.033
Nettowinst -12.693-3.908-17.70425.237-13.85514.972-12.274.461224.093-19.981-25.21-36.333-30.544-41.563-49.484-53.657-43.836-37.469-26.419-31.797-27.058-37.191-65.821-42.58-24.406-20.259-15.982-32.701-16.029-11.203-4.941
Nettowinstmarge -0.113-0.036-0.2220.303-0.2070.209-0.2540.0722.26-0.741-0.783-1.938-2.525-5.39500000000000000000
WPA (Winst Per Aandeel) -0.18-0.055-0.250.36-0.20.21-0.180.0643.23-0.29-0.36-0.53-0.44-0.61-0.72-0.79-0.66-0.65-0.48-0.58-0.49-0.68-1.27-0.88-0.51-1.11-0.34-1.01-0.49-0.35-0.15
Verwaterde WPA -0.18-0.055-0.250.35-0.20.21-0.180.0633.18-0.29-0.36-0.53-0.44-0.61-0.72-0.79-0.66-0.65-0.48-0.58-0.49-0.68-1.27-0.88-0.51-1.11-0.34-1.01-0.49-0.35-0.15
EBITDA -9.2590.313-16.0760.317-10.927-3.154-11.1966.04746.413-19.368-23.319-36.131-30.667-40.555-49.283-52.898-42.569-31.86-29.387-32.581-30.446-39.289-67.647-44.135-26.159-21.515-16.332-32.703-16.241-11.386-5.042
EBITDA ratio -0.0830.003-0.2010.004-0.163-0.044-0.2320.0980.468-0.718-0.724-1.928-2.536-5.26400000000000000000